title: Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome.
abstract: BACKGROUND
  Severe acute respiratory syndrome (SARS) is an emerging infectious disease, and indeed, the SARS epidemic in Taiwan from March to July 2003 had a great impact. This study depicts the clinical characteristics and short-term outcomes of patients with SARS treated at Taipei Veterans General Hospital; potential predictive factors for acute respiratory distress syndrome (ARDS) are also analyzed.
  
  
  METHODS
  This study retrospectively analyzed data for 67 SARS patients, who were grouped according to whether or not ARDS developed during the clinical course of SARS.
  
  
  RESULTS
  There were 32 males (mean age, 50.3 years; range, 20-75 years) and 35 females (mean age, 51.1 years; range, 23-86 years). Twenty-five patients (37.3%) were health care workers. At admission, 50 patients (74.6%) had abnormal chest radiographs, and all patients developed pulmonary infiltrates during the following week. During hospitalization, lymphopenia was found in 57 patients (85.1%); and elevated levels of lactate dehydrogenase (LDH; n = 55; 83.3%), C-reactive protein (n = 55; 83.3%), aminotransferases (n = 44; 65.7%), and creatine kinase (n = 14; 20.9%) were also noted. ARDS developed in 33 patients (49.3%), who were generally older than the patients in whom ARDS did not develop, male, non-health care workers, and who generally had dyspnea at the time of diagnosis, and a history of diabetes mellitus, hypertension or cerebrovascular accident. Patients with, versus those without, ARDS also tended to present with more severe lymphopenia and leukocytosis, and with higher levels of LDH and aspartate aminotransferase. The overall mortality rate was 31.3% (21/67), whereas the rate for patients who developed ARDS was 63.6% (21/33). Multivariate analyses showed that age greater than 65 years (odds ratio, OR, 10.6; 95% confidence interval, CI, 2.1-54.1), pre-existing diabetes mellitus (OR, 13.7; 95% CI, 1.3-146.9), and elevated levels of LDH (OR, 8.4; 95% CI, 1.9-36.9) at admission, were independent predictors of ARDS.
  
  
  CONCLUSIONS
  The clinical manifestations of SARS showed high variability, and were related to the underlying health status of individual patients. Importantly, the development of ARDS was associated with significant mortality, despite aggressive therapy.
authors.affiliation: Chest Department, Taipei Veterans General Hospital, Taiwan, ROC.
authors.forename: Cheng-Yu
authors.initials: CY
authors.lastname: Chen
authors.forename: Chen-Hsen
authors.initials: CH
authors.lastname: Lee
authors.forename: Cheng-Yi
authors.initials: CY
authors.lastname: Liu
authors.forename: Jia-Horng
authors.initials: JH
authors.lastname: Wang
authors.forename: Lee-Min
authors.initials: LM
authors.lastname: Wang
authors.forename: Reury-Perng
authors.initials: RP
authors.lastname: Perng
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006761:Hospitals; D006801:Humans; D007297:Inpatients; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012128:Respiratory Distress Syndrome / Q000209:etiology*; D012189:Retrospective Studies; D012307:Risk Factors; D045169:Severe Acute Respiratory Syndrome / Q000150:complications* / Q000473:pathology / Q000628:therapy; D013624:Taiwan
references.citation: N Engl J Med. 2003 May 15;348(20):1977-85
references.pmid: 12671062
references.citation: Emerg Infect Dis. 2003 Jun;9(6):718-20
references.pmid: 12781013
references.citation: N Engl J Med. 2003 May 15;348(20):1986-94
references.pmid: 12682352
references.citation: Radiology. 2003 Aug;228(2):395-400
references.pmid: 12738877
references.citation: Clin Infect Dis. 2000 Jul;31(1):96-100
references.pmid: 10913403
references.citation: J Infect Dis. 2002 May 1;185(9):1338-41
references.pmid: 12001053
references.citation: N Engl J Med. 2003 May 15;348(20):1995-2005
references.pmid: 12671061
references.citation: BMJ. 2003 Jun 21;326(7403):1354-8
references.pmid: 12816820
references.citation: MMWR Morb Mortal Wkly Rep. 2003 May 23;52(20):461-6
references.pmid: 12807078
references.citation: Radiology. 2003 Aug;228(2):401-6
references.pmid: 12759474
references.citation: Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):818-24
references.pmid: 7509706
references.citation: J Chin Med Assoc. 2003 Jun;66(6):328-38
references.pmid: 12889501
references.citation: Clin Chem. 2003 Jun;49(6 Pt 1):953-5
references.pmid: 12765993
references.citation: Lancet. 2003 Apr 19;361(9366):1319-25
references.pmid: 12711465
references.citation: N Engl J Med. 2003 May 15;348(20):1953-66
references.pmid: 12690092
references.citation: JAMA. 2003 Jun 4;289(21):2801-9
references.pmid: 12734147
references.citation: N Engl J Med. 2003 May 15;348(20):1967-76
references.pmid: 12690091
references.citation: N Engl J Med. 2003 May 15;348(20):e6-7
references.pmid: 12671060